Salvatore Privitera - 02 Sep 2026 Form 4 Insider Report for AtriCure, Inc. (ATRC)

Reporting relationship: Chief Technical Officer
Issuer ticker: ATRC
Reported as of: 02 Sep 2026
Net transaction value: -$407,558
SEC form: 4
Accepted by SEC: 04 Sep 2026, 07:39:29 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Salvatore Privitera

Key filing fact

Salvatore Privitera filed Form 4 for AtriCure, Inc. (ATRC) on 04 Sep 2026.

Key facts

This page summarizes Salvatore Privitera's Form 4 filing for AtriCure, Inc. (ATRC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 04 Sep 2026, 07:39.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$407,558.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001336063 Primary reporting owner

Privitera Salvatore

Relationship: Chief Technical Officer
Address: 7555 INNOVATION WAY, MASON
Signature: /s/ Salvatore Privitera
Signature date: 04 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ATRC transaction

Common Stock

Sale

Transaction value: $407,558
Shares: -7,763
Change %: -4.9%
Price: $52.50
Shares after: 150,921
Date: 02 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 1 footnote

Footnote F1

These shares were sold pursuant to a 10b5-1 trading plan adopted on February 20, 2026.